FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
GSK completes acquisition of 35Pharma Inc.
GSK plc has completed the acquisition of 35Pharma Inc., adding HS235, a…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…